Compare AXGN & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | TWST |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | N/A | 2018 |
| Metric | AXGN | TWST |
|---|---|---|
| Price | $29.78 | $31.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $33.67 | ★ $46.33 |
| AVG Volume (30 Days) | 992.8K | ★ 1.8M |
| Earning Date | 10-29-2025 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $214,709,000.00 | ★ $376,572,000.00 |
| Revenue This Year | $21.57 | $15.19 |
| Revenue Next Year | $15.79 | $15.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 18.72 | ★ 20.32 |
| 52 Week Low | $9.22 | $23.30 |
| 52 Week High | $34.24 | $55.33 |
| Indicator | AXGN | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 60.09 | 52.20 |
| Support Level | $28.88 | $31.19 |
| Resistance Level | $30.76 | $33.31 |
| Average True Range (ATR) | 1.48 | 1.68 |
| MACD | -0.26 | 0.13 |
| Stochastic Oscillator | 32.64 | 55.76 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.